Matrix-associated autologous chondrocyte implantation on the knee joint reimbursed in Germany

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

M-ACI will be included in Annex I of the G-BA Directive on ambulatory care methods. Annex I lists all medical examination and treatment methods recognized by the G-BA. These methods are reimbursed at the expense of statutory health insurance. The M-ACI will only be reimbursed in patients with a symptomatic articular cartilage defect of the knee joint of severity III or IV according to the classification of the International Cartilage Repair Society.

Moreover, the G-BA Directive “Methods of examination and treatment in hospital settings” will be updated in the following way:

  • The method of collagen-covered and periosteum-covered autologous chondrocyte implantation on the knee joint will be introduced under the §4 of the Directive, which includes the methods that are excluded from reimbursement within the statutory health insurance;
  • Also, the method of M-ACI on the knee joint will be included in Annex I of the abovementioned Directive. Annex I lists methods that have been assessed by the G-BA were considered as necessary and therefore are reimbursed.

The outlined changes will come into force after the publication of the respective decisions in the Federal Gazette (Bundesanzeiger).

The full details in German can be found here and here.

This news is just one of about 300 market access news collected by our team in the subscription services “HTA Alerts” and “Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

29

Nov 2022

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced that sixteen applications for Innovation Funding of the new forms of care were accepted. These applications relate to the funding announcement of March 17, 2021. Most projects relate to interdisciplinary or cross-sectoral care and pathways.

Read more

24

Nov 2022

In November 2022, NHS Digital published a final summary of core changes from OPCS-4.9 to OPCS-4.10 to be introduced from April 01, 2023. OPCS-4 is a statistical classification for clinical coding of interventions and procedures undertaken within the NHS. It is updated every three years. A total of 236 new four-character codes will be implemented in OPCS-4.10. Key changes concern cardiovascular, gastrointestinal, endoscopy, ENT, nephrology and urology, neurology and neurosurgery, obstetrics and gynecology, orthopedic, and breast surgery fields.

Read more

23

Nov 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Read more

22

Nov 2022

On October 27, 2022, the BfArM (Federal Institute for Drugs and Medical Devices) published the final version of the 2023 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care in Germany.

Read more

18

Nov 2022

On October 28, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) reported that 231 applications were received for innovation funding of healthcare research projects.

Read more